Johnson & Johnson sues Biden administration over Medicare drug price negotiations
Johnson & Johnson sued the Biden administration over Medicare’s new powers to slash drug prices, making it the third pharmaceutical company to challenge the controversial provision of the Inflation Reduction Act.
![](https://kbin.life/media/cache/resolve/entry_thumb/f6/a5/f6a52940632ef86b92d70eaada6112443d553fa85afa117b2822a1b92cbbcc78.jpg)